Home > Insider Trading > Filing (0001179110-20-001738)

Filing Details

Accession Number:: 0001179110-20-001738
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-18 14:38:50
Reporting Period:: 2020-02-13

Accepted Time:: 2020-02-18 14:38:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926326	Omnicell Inc	OMCL	Electronic Computers (3571)	943166458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1651691	J. Peter Kuipers	590 E. Middlefield Rd Mountain View CA 94043	Executive V P& Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-02-13	6,653	$0.00	53,031	No	4	A	Direct
Common Stock	Acquisiton	2020-02-13	5,987	$0.00	59,018	No	4	A	Direct
Common Stock	Acquisiton	2020-02-14	11,267	$0.00	70,285	No	4	M	Direct
Common Stock	Disposition	2020-02-14	7,411	$89.79	62,874	No	4	S	Direct
Common Stock	Disposition	2020-02-14	3,856	$89.79	59,018	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options NQ (Right to Buy)	Acquisiton	2020-02-13	25,618	$0.00	25,618	$90.19
Common Stock	Stock Options NQ (Right to Buy)	Disposition	2020-02-14	3,125	$0.00	3,125	$32.78
Common Stock	Stock Options NQ (Right to Buy)	Disposition	2020-02-14	3,267	$0.00	3,267	$27.70
Common Stock	Stock Options NQ (Right to Buy)	Disposition	2020-02-14	4,875	$0.00	4,875	$36.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,618	2021-02-13	2030-02-12	No	4	A	Direct
0	2016-09-01	2025-08-31	No	4	M	Direct
0	2017-02-04	2026-02-03	No	4	M	Direct
0	2018-02-08	2027-02-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,378	Direct

Footnotes

The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2021 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2021 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance.
RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years.
NQ: Shares shall vest ratably over 48 month period, with a year cliff.
The price reported in Column 4 is the average price of $89.7876. The sold price range between $89.09 to $89.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
The price reported in Column 4 is the average price of $89.7876. The sold price range between $90.02 to $90.38. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote